COO - The Cooper Companies, Common Stock
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US2166484020
Contact Lenses, Fertility Products, Surgical Instruments
The Cooper Companies, Inc. is a global medical device company that specializes in developing, manufacturing, and marketing a wide range of products for contact lens wearers and healthcare professionals. The company operates through two main segments: CooperVision and CooperSurgical.
The CooperVision segment is a leading provider of contact lenses, offering a comprehensive portfolio of spherical lenses that correct near and farsightedness, as well as toric and multifocal lenses that address vision challenges such as astigmatism, presbyopia, and myopia. With a strong presence in the Americas, Europe, Middle East, Africa, and Asia Pacific, CooperVision is committed to improving the way people see the world.
The CooperSurgical segment focuses on family and women's healthcare, providing a diverse range of fertility products and services, medical devices, and contraception to healthcare professionals and patients worldwide. Its product portfolio includes surgical and office products, such as endosee endometrial imaging products, fetal pillow cephalic elevation devices, and uterine positioning products, as well as cryostorage services for cord blood and cord tissue storage. Additionally, the segment offers fertility products and services, including fertility consumables and equipment, donor gamete services, and genomic services, such as genetic testing.
The company's products are sold to a wide range of customers, including distributors, group purchasing organizations, eye care and healthcare professionals, independent practices, corporate retailers, hospitals, clinics, and authorized resellers. With a rich history dating back to 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California, and is committed to delivering innovative solutions that improve the lives of people around the world.
For more information about The Cooper Companies, Inc., please visit their website at https://www.coopercos.com.
Drawdown (Underwater) Chart
![Drawdown / Underwater Chart for COO - The Cooper Companies, Common Stock](https://www.valueray.com/images/drawdown_chart/COO.NASDAQ_drawdown.png)
Overall Trend and Yearly Seasonality
![Drawdown / Underwater Chart for COO - The Cooper Companies, Common Stock](https://www.valueray.com/images/chart/COO.NASDAQ_seasonality.png)
COO Stock Overview
Market Cap in USD | 21,053m |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
GiC SubIndustry | Health Care Supplies |
TER | 0.00% |
IPO / Inception | 1983-12-30 |
COO Stock Ratings
Growth 5y | 31.7 |
Fundamental | 24.8 |
Dividend | 7.00 |
Rel. Performance vs Sector | -0.21 |
Analysts | 4.18/5 |
Fair Price Momentum | 100.39 USD |
Fair Price DCF | 9.19 USD |
COO Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | 0.00% |
Dividends CAGR 5y | 0.00% |
Payout Consistency | 64.0% |
COO Growth Ratios
Growth 12m | 21.81% |
Growth Correlation 12m | 51% |
Growth Correlation 3m | 53% |
CAGR 5y | 7.45% |
CAGR/Mean DD 5y | 0.49 |
Sharpe Ratio 12m | 0.63 |
Alpha vs SP500 12m | -0.58 |
Beta vs SP500 5y weekly | 0.97 |
ValueRay RSI | 93.89 |
Volatility GJR Garch 1y | 20.84% |
Price / SMA 50 | 14.64% |
Price / SMA 200 | 13.89% |
Current Volume | 1235.7k |
Average Volume 20d | 1235.2k |
External Links for COO Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of September 08, 2024, the stock is trading at USD 106.59 with a total of 1,235,653 shares traded.
Over the past week, the price has changed by +0.81%, over one month by +15.24%, over three months by +11.91% and over the past year by +21.27%.
According to ValueRays Forecast Model, COO The Cooper Companies, Common Stock will be worth about 110.8 in September 2025. The stock is currently trading at 106.59. This means that the stock has a potential upside of +3.9%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 108.9 | 2.13 |
Analysts Target Price | 400.2 | 275 |
ValueRay Target Price | 110.8 | 3.90 |